$38.87 +0.98 (%) Myriad Genetics Inc - NASDAQ

Sep. 29, 2014 | 04:00 PM

Partner Headlines

  1. Myriad Reports Tumor Bracanalysis CDX Has Identified 44% More Candidates for PARP Therapy

    Benzinga | Sep. 29, 2014 | 07:40AM EST
  2. Myriad myPath Melanoma Test Reduced Indeterminate Cases By 76% And Changed Treatment In 35 % Of Cases

    Benzinga | Sep. 9, 2014 | 07:08AM EST
  3. Myriad Publishes myRisk Hereditary Cancer Study In Cancer

    Benzinga | Sep. 3, 2014 | 16:06PM EST
  4. FuelCell Upgrade; Amazon Announces New Product

    Benzinga | Aug. 13, 2014 | 15:28PM EST
  5. SeaWorld Drops On Downbeat Results; Canadian Solar Shares Surge

    Benzinga | Aug. 13, 2014 | 12:49PM EST
  6. Myriad Genetics Gets Mixed Analyst Reaction For Q2

    IBD | Aug. 13, 2014 | 12:13PM EST
  7. Markets Rise; Macy's Lowers Comparable Sales Outlook

    Benzinga | Aug. 13, 2014 | 10:59AM EST
  8. Morning Market Losers

    Benzinga | Aug. 13, 2014 | 09:51AM EST
  9. Myriad Genetics Guidance Disappoints, Q4 Edges Views

    IBD | Aug. 12, 2014 | 19:16PM EST
  10. Myriad issues weak guidance

    IBD | Aug. 12, 2014 | 18:51PM EST
  11. Earnings Scheduled For August 12, 2014

    Benzinga | Aug. 12, 2014 | 05:16AM EST
  12. Nasdaq Leads Up Session; Strong Earnings Lift Tata Motors

    IBD | Aug. 11, 2014 | 16:20PM EST
  13. Myriad Genetics' Earnings Face 'Angelina Jolie' Comps

    IBD | Aug. 11, 2014 | 12:43PM EST
  14. Top 4 Stocks In The Research Services Industry With The Highest Profit Margin

    Benzinga | Aug. 1, 2014 | 05:16AM EST
  15. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest EPS

    Benzinga | Jul. 18, 2014 | 04:36AM EST
  16. Some Stock Leaders Stay Firm Amid Pullback

    IBD | Jul. 10, 2014 | 18:43PM EST
  17. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD | Jul. 7, 2014 | 11:47AM EST
  18. Novo, Other Medicals Display Healthy Action

    IBD | Jun. 26, 2014 | 18:41PM EST
  19. A Few Medical Research Stocks Break Out, Others Basing

    IBD | Jun. 9, 2014 | 18:53PM EST
  20. MYRIAD GENETICS

    IBD | Jun. 9, 2014 | 18:39PM EST
  21. Quiet Session Intensifies As Stocks Hit Session Lows

    IBD | May. 6, 2014 | 15:01PM EST
  22. Stocks Extend Losses; AerCap Hits High On Earnings

    IBD | May. 6, 2014 | 11:56AM EST
  23. Myriad Genetics and UnitedHealthcare Sign 3 Yr Deal To Make Cancer Tests Available To United Members

    Benzinga | May. 6, 2014 | 07:16AM EST
  24. Earnings Scheduled For May 6, 2014

    Benzinga | May. 6, 2014 | 05:33AM EST
  25. Ubiquiti, Avis Budget Among 5 IBD 50 Stocks Reporting

    IBD | May. 3, 2014 | 08:02AM EST
  26. Why I Bought Myriad Genetics (MYGN)

    GuruFocus | Apr. 28, 2014 | 09:29AM EST
  27. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest Revenue

    Benzinga | Apr. 23, 2014 | 04:31AM EST
  28. Myriad Genetics Is Saving Lives With New Products

    IBD | Apr. 17, 2014 | 15:50PM EST
  29. Analyst Bullish On Medical Research, Equipment Stocks

    IBD | Apr. 8, 2014 | 13:33PM EST
  30. Myriad, Tata Motors Among RS Leaders In Correction

    IBD | Apr. 8, 2014 | 08:02AM EST
  31. UPDATE: Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)

    Benzinga | Apr. 7, 2014 | 16:31PM EST
  32. Avis Budget Leads 5 IBD 50 Stocks Holding Up Well

    IBD | Apr. 5, 2014 | 08:02AM EST
  33. Stocks Jump, Then Trim Gains; Anadarko, Align Rock Ahead

    IBD | Apr. 4, 2014 | 10:31AM EST
  34. Myriad soars to a 5-year high

    IBD | Apr. 2, 2014 | 19:13PM EST
  35. Myriad Gaps Up To High On Reimbursement Rate Change

    IBD | Apr. 2, 2014 | 18:11PM EST
  36. Indexes Extend Win Streak As S&P 500 Marks New High

    IBD | Apr. 2, 2014 | 17:28PM EST
  37. Mid-Afternoon Market Update: MannKind Hangs Onto its Gains as Yelp Shares Drop

    Benzinga | Apr. 2, 2014 | 15:33PM EST
  38. Indexes Hold Modest Gains; Under Armour On The Move

    IBD | Apr. 2, 2014 | 13:20PM EST
  39. Mid-Day Market Update: Apollo Drops After Q2 Results; MannKind Shares Spike Higher

    Benzinga | Apr. 2, 2014 | 12:31PM EST
  40. Indexes Edge Higher; Rubicon Project Soars In Debut

    IBD | Apr. 2, 2014 | 12:04PM EST
  41. Myriad Genetics Soars On CMS Reimbursement Increase

    IBD | Apr. 2, 2014 | 11:31AM EST
  42. Mid-Morning Market Update: Markets Flat; Monsanto Earnings Beat Street View

    Benzinga | Apr. 2, 2014 | 10:38AM EST
  43. Benzinga's Volume Movers

    Benzinga | Apr. 2, 2014 | 10:35AM EST
  44. Stocks Whittle Opening Gains; Apollo Tumbles, Despite Upgrade

    IBD | Apr. 2, 2014 | 10:30AM EST
  45. Morning Market Movers

    Benzinga | Apr. 2, 2014 | 09:40AM EST
  46. Jobs Data Trim Stock Futures; Myriad Genetics Spikes

    IBD | Apr. 2, 2014 | 08:57AM EST
  47. J.P. Morgan Reinstates Underweight Rating on Myriad Over LT Outlook Concerns

    Benzinga | Mar. 31, 2014 | 10:41AM EST
  48. Top 4 Stocks In The Research Services Industry With The Lowest PEG Ratio

    Benzinga | Mar. 27, 2014 | 04:30AM EST
  49. Myriad falls on rival product

    IBD | Mar. 11, 2014 | 18:47PM EST
  50. General Motors, Tesla Motors Under Late Pressure

    IBD | Mar. 11, 2014 | 16:56PM EST
Trading Center